Regenxbio (RGNX) Short-term Investments (2015 - 2026)

Regenxbio's Short-term Investments history runs 11 years deep, the most recent figure standing at $195.6 million for Q4 2025.

• In Q4 2025, Short-term Investments rose 10.41% year-over-year to $195.6 million; the TTM figure through Dec 2025 stood at $195.6 million (up 10.41% YoY), while the FY2025 annual figure was $195.6 million, up 10.41% from the prior year.
• Short-term Investments for Q4 2025 stood at $195.6 million, down from $215.4 million in the prior quarter.
• The five-year high for Short-term Investments was $281.6 million in Q2 2022, with the low at $111.5 million in Q3 2021.
• The 5-year median for Short-term Investments is $220.6 million (2024), against an average of $206.8 million.
• The sharpest annual moves came in 2022 and 2025: Short-term Investments surged 139.31% in 2022, then plunged 38.97% in 2025.
• Regenxbio's Short-term Investments stood at $112.2 million in 2021, then jumped by 138.52% to $267.7 million in 2022, then declined by 10.07% to $240.7 million in 2023, then declined by 26.41% to $177.2 million in 2024, then advanced by 10.41% to $195.6 million in 2025.
• Business Quant data shows RGNX's Short-term Investments at $195.6 million in Q4 2025, $215.4 million in Q3 2025, and $243.7 million in Q2 2025.